FI972780A - Apoptoosia muuntava koostumus, joka sisältää tekijän, joka vaikuttaa metionaalin ja malonidialdehydin solunsisäiseen tasoon - Google Patents

Apoptoosia muuntava koostumus, joka sisältää tekijän, joka vaikuttaa metionaalin ja malonidialdehydin solunsisäiseen tasoon Download PDF

Info

Publication number
FI972780A
FI972780A FI972780A FI972780A FI972780A FI 972780 A FI972780 A FI 972780A FI 972780 A FI972780 A FI 972780A FI 972780 A FI972780 A FI 972780A FI 972780 A FI972780 A FI 972780A
Authority
FI
Finland
Prior art keywords
methional
malondialdehyde
composition containing
factor affecting
modifying composition
Prior art date
Application number
FI972780A
Other languages
English (en)
Swedish (sv)
Other versions
FI972780A0 (fi
Inventor
Gerard Anthony Quash
Alain Doutheau
Original Assignee
Rech Dermatologieques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rech Dermatologieques Galderma filed Critical Rech Dermatologieques Galderma
Publication of FI972780A0 publication Critical patent/FI972780A0/fi
Publication of FI972780A publication Critical patent/FI972780A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI972780A 1994-12-29 1997-06-27 Apoptoosia muuntava koostumus, joka sisältää tekijän, joka vaikuttaa metionaalin ja malonidialdehydin solunsisäiseen tasoon FI972780A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9415884A FR2728790B1 (fr) 1994-12-29 1994-12-29 Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial
PCT/FR1995/001715 WO1996020701A1 (fr) 1994-12-29 1995-12-22 Composition modulant l'apoptose comprenant un facteur influençant le taux intracellulaire de methional ou de malondialdehyde

Publications (2)

Publication Number Publication Date
FI972780A0 FI972780A0 (fi) 1997-06-27
FI972780A true FI972780A (fi) 1997-06-27

Family

ID=9470424

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972780A FI972780A (fi) 1994-12-29 1997-06-27 Apoptoosia muuntava koostumus, joka sisältää tekijän, joka vaikuttaa metionaalin ja malonidialdehydin solunsisäiseen tasoon

Country Status (24)

Country Link
US (1) US5744499A (fi)
EP (1) EP0723778B1 (fi)
JP (1) JP2000515845A (fi)
KR (1) KR100310499B1 (fi)
AR (1) AR001783A1 (fi)
AT (1) ATE191339T1 (fi)
AU (1) AU704064B2 (fi)
BR (1) BR9510509A (fi)
CA (1) CA2166243C (fi)
DE (1) DE69516107T2 (fi)
DK (1) DK0723778T3 (fi)
ES (1) ES2147272T3 (fi)
FI (1) FI972780A (fi)
FR (1) FR2728790B1 (fi)
GR (1) GR3033732T3 (fi)
HU (1) HUT77490A (fi)
IL (1) IL116586A0 (fi)
NO (1) NO973034L (fi)
NZ (1) NZ298831A (fi)
PL (1) PL182597B1 (fi)
PT (1) PT723778E (fi)
RU (1) RU2160103C2 (fi)
WO (1) WO1996020701A1 (fi)
ZA (1) ZA9511015B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9517622D0 (en) * 1995-08-29 1995-11-01 Univ Edinburgh Regulation of intracellular glucocorticoid concentrations
FR2761606B1 (fr) * 1997-04-08 1999-05-14 Cird Galderma Utilisation de derives aminothiolesters dans le domaine pharmaceutique
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
EP0908179A1 (en) * 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
US7951989B2 (en) * 1998-02-23 2011-05-31 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
US6656449B1 (en) * 1998-02-23 2003-12-02 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
AU749688B2 (en) * 1998-02-23 2002-07-04 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
BR9908713A (pt) * 1998-03-16 2000-11-21 Somerset Pharmaceuticals Inc Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
FR2777001B1 (fr) * 1998-04-01 2000-06-09 Cird Galderma Derives de l'acide 6,8-dimercaptooctanoique substitues en 6-s et/ou en 8-s par le radical (3-methylthiopropanoyl) et compositions pharmaceutiques destinees au traitement des tumeurs cancereuses
TW544310B (en) 1998-04-02 2003-08-01 Ajinomoto Kk Amino acid derivatives and anti-inflammatory agents
EP1135531B1 (en) 1998-12-01 2007-05-02 Phylonix Pharmaceuticals Inc. Methods for introducing heterologous cells into fish
AU1784301A (en) * 1999-11-24 2001-06-04 Alticor Inc. Topical skin composition
ES2531547T3 (es) * 1999-12-06 2015-03-17 Geistlich Pharma Ag Uso de taurolidina o el taurultamo para la fabricación de un medicamento para el tratamiento de tumores
US20080124409A1 (en) * 2000-11-21 2008-05-29 Access Business Group International Llc Topical Skin Compositions, Their Preparation, and Their Use
US20070003536A1 (en) * 2000-11-21 2007-01-04 Zimmerman Amy C Topical skin compositions, their preparation, and their use
JP2004532245A (ja) * 2001-05-15 2004-10-21 ページ ダブル フォーク 癌を治療するための生体影響性化合物の標的送達
US20030129262A1 (en) * 2001-08-30 2003-07-10 Epner Daniel E. Methionine restriction for cancer therapy
US20030143645A1 (en) * 2001-09-14 2003-07-31 Haystead Timothy A. Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets
JP2004020220A (ja) * 2002-06-12 2004-01-22 Pioneer Electronic Corp 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム
US20050152995A1 (en) * 2003-06-27 2005-07-14 Chen Dong F. Methods and compositions for promoting axon regeneration and cell replacement therapy
WO2009144253A1 (en) * 2008-05-29 2009-12-03 Karolinska Institutet Innovations Ab Compounds comprising a 3-pyridinol or 5-pyrimidinol ring having an organoseleno or organotelluro substituent for use as antioxidants
SE537517C2 (sv) 2012-12-14 2015-05-26 Stora Enso Oyj Våtlagt arkmaterial innefattande mikrofibrillerad cellulosasamt förfarande för tillverkning därav
WO2017005910A1 (en) * 2015-07-09 2017-01-12 Metabolic Explorer Methionine hydroxy analog (mha) pathways for production by fermentation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5716898A (en) * 1980-07-03 1982-01-28 Kureha Chem Ind Co Ltd Prostaglandin controller containing aminobenzoic derivative
HU201240B (en) * 1987-03-18 1990-10-28 Caola Kozmetikai Cosmetical composition for regeneration of skin
FR2673530B1 (fr) * 1991-03-06 1995-05-19 Monique Moreau Extraits de feuilles de murier, antiradicalaires et antimalondialdehyde.

Also Published As

Publication number Publication date
FI972780A0 (fi) 1997-06-27
ATE191339T1 (de) 2000-04-15
IL116586A0 (en) 1996-03-31
ZA9511015B (en) 1996-08-12
KR970706807A (ko) 1997-12-01
DK0723778T3 (da) 2000-07-10
PL182597B1 (pl) 2002-02-28
GR3033732T3 (en) 2000-10-31
EP0723778B1 (fr) 2000-04-05
PL320963A1 (en) 1997-11-24
CA2166243C (fr) 2003-07-01
ES2147272T3 (es) 2000-09-01
US5744499A (en) 1998-04-28
RU2160103C2 (ru) 2000-12-10
FR2728790B1 (fr) 1997-01-24
HUT77490A (hu) 1998-05-28
AU4451296A (en) 1996-07-24
EP0723778A1 (fr) 1996-07-31
MX9704491A (es) 1997-10-31
KR100310499B1 (ko) 2001-12-12
AU704064B2 (en) 1999-04-15
FR2728790A1 (fr) 1996-07-05
WO1996020701A1 (fr) 1996-07-11
DE69516107T2 (de) 2000-11-16
JP2000515845A (ja) 2000-11-28
NO973034L (no) 1997-08-29
NZ298831A (en) 2001-04-27
PT723778E (pt) 2000-09-29
DE69516107D1 (de) 2000-05-11
AR001783A1 (es) 1997-12-10
CA2166243A1 (fr) 1996-06-30
NO973034D0 (no) 1997-06-27
BR9510509A (pt) 1998-07-07

Similar Documents

Publication Publication Date Title
FI972780A (fi) Apoptoosia muuntava koostumus, joka sisältää tekijän, joka vaikuttaa metionaalin ja malonidialdehydin solunsisäiseen tasoon
FI934373A (fi) Fabrikationsprocess av komposittraod och kompositprodukter som faotts avnaemnda traoden
DE69321479T2 (de) Retinol enthaltende kosmetische zusammensetzung
DE69315083D1 (de) Retinol enthaltende kosmetische zusammensetzung
ITRM910952A0 (it) Composizioni farmaceutiche contenenti gonadotropine
FI931161A0 (fi) Kompositioner innehaollande estrar av karboxylhaltiga interpolymerer och anvaendning av dessa
DE69318335D1 (de) Dentale Filmverpackung
AU634358B2 (en) Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic
FI925704A0 (fi) Foerfarande och anlaeggning foer bestrykning av vals i en filmlimpress
FI943391A0 (fi) Paperin päällystekoostumus
FI931311A (fi) Soenderfallning motstaoende papper foer en kruka foer odling och saettning av plantor och foerfarande foer framstaellning av detta
IT9019389A0 (it) Luxmetri contenenti sostanze fotocromatiche
NO933287L (no) Anvendelse av tiadiazoler som biocider for beskyttelse av materialer
EP0464521A3 (en) Polysulfide compounds and lipid peroxidation inhibitor containing the polysulfide compounds as active ingredient
DK51993D0 (da) Emballageemne af pulpmateriale
KR940005548U (ko) 포장상자의 칸막이
NO920272D0 (no) Hydrofile-hydrofobe derivater av polygalaktomannaner inneholdende tertiaer aminfunksjonalitet
DE69122063D1 (de) Tetrapolyimid-Film enthaltend oxydiphthalisches Dianhydrid
FI942331A0 (fi) Biosidisia koostumuksia ja niiden käyttö
NO931916D0 (no) Komposittmaterialer inneholdende traader av polyeterketoner
DK146192D0 (da) Emballageemne af pulpmateriale
DK118692D0 (da) Emballageemne af pulpmateriale
KR920006306U (ko) 껌 포장지의 3도 인날기
KR940024222U (ko) 약 포장지의 제조장치
KR920002539U (ko) 용기의 패킹구조

Legal Events

Date Code Title Description
MA Patent expired